103 related articles for article (PubMed ID: 12152998)
21. [Differential expression genes in various phases of chronic myeloid leukemia by cDNA microarray].
Gao SJ; Zhu X; Yao C; Li W; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):575-8. PubMed ID: 20561404
[TBL] [Abstract][Full Text] [Related]
22. [Imatinib therapy in chronic myeloid leukemia].
Egyed M; Kollár B; Rajnics P; Karádi E; Matolcsi A
Orv Hetil; 2008 Aug; 149(32):1509-12. PubMed ID: 18672441
[TBL] [Abstract][Full Text] [Related]
23. The negative prognostic impact of derivative 9 deletions in patients who received hydroxyurea treatment for chronic myelogenous leukemia in the chronic phase.
Li JY; Xu W; Wu W; Zhu Y; Qiu HR; Zhang R; Zhang SJ; Qian SX
Onkologie; 2008 Nov; 31(11):585-9. PubMed ID: 19145090
[TBL] [Abstract][Full Text] [Related]
24. The impact of gene profiling in chronic myeloid leukaemia.
Yong AS; Melo JV
Best Pract Res Clin Haematol; 2009 Jun; 22(2):181-90. PubMed ID: 19698927
[TBL] [Abstract][Full Text] [Related]
25. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
Schulze E; Krahl R; Thalmeier K; Helbig W
Exp Hematol; 1995 Dec; 23(14):1649-54. PubMed ID: 8542960
[TBL] [Abstract][Full Text] [Related]
26. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine kinase-1 mediates BCR/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells.
Li QF; Huang WR; Duan HF; Wang H; Wu CT; Wang LS
Oncogene; 2007 Dec; 26(57):7904-8. PubMed ID: 17599053
[TBL] [Abstract][Full Text] [Related]
28. [P-glycoprotein and treatment with plicamycin + hydroxyurea in myeloid blastic crisis of chronic myeloid leukemia].
Carulli G; Marini A; Caracciolo F
Medicina (Firenze); 1989; 9(4):409-10. PubMed ID: 2576761
[TBL] [Abstract][Full Text] [Related]
29. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
Wang DP; Liang MY; Zhang XH; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
[TBL] [Abstract][Full Text] [Related]
30. Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
Vaiopoulos G; Terpos E; Viniou N; Nodaros K; Rombos J; Loukopoulos D
Am J Hematol; 2001 Jan; 66(1):57-8. PubMed ID: 11426495
[TBL] [Abstract][Full Text] [Related]
31. Reversible leg ulcer due to hydroxyurea in a case of chronic myeloid leukemia.
Tripathi AK; Ahmad R; Sawlani KK
J Assoc Physicians India; 2003 Oct; 51():1014-5. PubMed ID: 14719596
[TBL] [Abstract][Full Text] [Related]
32. Distinct molecular phenotype of malignant CD34(+) hematopoietic stem and progenitor cells in chronic myelogenous leukemia.
Kronenwett R; Butterweck U; Steidl U; Kliszewski S; Neumann F; Bork S; Blanco ED; Roes N; Gräf T; Brors B; Eils R; Maercker C; Kobbe G; Gattermann N; Haas R
Oncogene; 2005 Aug; 24(34):5313-24. PubMed ID: 15806158
[TBL] [Abstract][Full Text] [Related]
33. [Chronic myeloid leukemia. What's in the future therapy in Black Africa?].
Dokekias AE; Malanda F; Mbalawa ChG
Tunis Med; 2003 Mar; 81(3):172-9. PubMed ID: 12793067
[No Abstract] [Full Text] [Related]
34. The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation.
Rahmani M; Nguyen TK; Dent P; Grant S
Mol Pharmacol; 2007 Sep; 72(3):788-95. PubMed ID: 17595328
[TBL] [Abstract][Full Text] [Related]
35. [Effect of IFN-α on Cytokines in Serum of Patients with Chronic Myeloid Leukemia].
Wu Y; Cheng Z; Shi L; Feng L; Li YM; Lyu DL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):99-103. PubMed ID: 28245383
[TBL] [Abstract][Full Text] [Related]
36. Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.
Hehlmann R; Berger U; Pfirrmann M; Hochhaus A; Metzgeroth G; Maywald O; Hasford J; Reiter A; Hossfeld DK; Kolb HJ; Löffler H; Pralle H; Queisser W; Griesshammer M; Nerl C; Kuse R; Tobler A; Eimermacher H; Tichelli A; Aul C; Wilhelm M; Fischer JT; Perker M; Scheid C; Schenk M; Weiss J; Meier CR; Kremers S; Labedzki L; Schmeiser T; Lohrmann HP; Heimpel H;
Leukemia; 2003 Aug; 17(8):1529-37. PubMed ID: 12886239
[TBL] [Abstract][Full Text] [Related]
37. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
38. The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene.
Bousquet M; Quelen C; De Mas V; Duchayne E; Roquefeuil B; Delsol G; Laurent G; Dastugue N; Brousset P
Oncogene; 2005 Nov; 24(48):7248-52. PubMed ID: 16091753
[TBL] [Abstract][Full Text] [Related]
39. High-dose hydroxyurea and G-CSF to collect Philadelphia-negative cells in chronic myeloid leukemia: preliminary results.
Mehta J; Powles R; Singhal S; Swansbury GJ; Millar B; Shepherd V; Bell J; Min T; Cabral S; Treleaven J
Leuk Lymphoma; 1996 Sep; 23(1-2):107-11. PubMed ID: 9021692
[TBL] [Abstract][Full Text] [Related]
40. Analysis of gene expression profiles in an imatinib-resistant cell line, KCL22/SR.
Ohmine K; Nagai T; Tarumoto T; Miyoshi T; Muroi K; Mano H; Komatsu N; Takaku F; Ozawa K
Stem Cells; 2003; 21(3):315-21. PubMed ID: 12743326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
